When should a company move from grants to investment?
How to know when grant funding has done its job and equity is the next right step.
Key takeaway
How to know when grant funding has done its job and equity is the next right step. This guide weighs Innovate UK Smart Grants, Innovate UK Innovation Loans, Seed Enterprise Investment Scheme (SEIS) against your stage, funding type and timeline using verified FundingAtlas data, and explains when each is the right call.
The question
How to know when grant funding has done its job and equity is the next right step.
Key considerations
The factors that should shape your decision before you commit operator hours to an application.
| Funding stage | any, growth, startup |
|---|---|
| Funding type | grant, loan, tax_incentive, equity |
| Funding amount | Innovate UK Smart Grants: £100k–£2m • Innovate UK Innovation Loans: £100k–£2m • Seed Enterprise Investment Scheme (SEIS): Up to £250k raised • Enterprise Investment Scheme (EIS): Up to £12m raised • British Patient Capital: Funding levels vary and should be confirmed through the official scheme guidance. • R&D Tax Relief: Up to ~27p per £1 of R&D spend |
| Eligibility | UK-registered businesses of any size carrying out R&D in the UK. |
| Timeline | Realistic working timeline: • **Weeks -8 to -6:** Competition scope review, eligibility check, decision to bid. • **Weeks -6 to -3:** Drafting — technical, commercial, team, project plan sections in parallel. • **Weeks -3 to -1:** Budget finalisation, match funding evidence, internal review, external critical review. • **Final week:** IFS portal upload, finance form, validation, submission at least 24 hours before deadline (the portal slows materially in the final hours). • **Post-submission:** Decision typically 8–12 weeks after the competition closes. Successful applicants enter Project Setup; unsuccessful applicants receive scored feedback that is genuinely useful for a future attempt. |
| Region | Some programmes are England-only, others run across the devolved nations or are restricted to combined-authority footprints. Check each official source. |
Recommended route
**Quick Answer**
You move from grants to investment when the *commercial* risk, not the *technical* risk, has become the binding constraint. Grants exist to de-risk technology. Equity exists to scale a proven commercial model. The transition rarely happens cleanly — most healthy UK innovators run both in parallel for several years.
**Signals you are ready for investment**
- A working product with paying or actively-piloting customers. - Repeatable commercial motion (sales cycle, channel, unit economics). - A 12–24-month plan that needs working capital, not just R&D capital. - Founders comfortable with the dilution and governance that come with equity.
**Signals you are still grant-stage**
- The next milestone is technical (prototype, pilot, certification), not commercial. - The proposition is not yet defensible to a Series A investor. - A grant or innovation loan would unlock the next milestone for less dilution.
**Sequencing in practice**
Most UK deep-tech companies follow: Innovate UK Smart Grants and R&D Tax Relief → SEIS → Innovation Loans for late-stage R&D → EIS for commercialisation → British Patient Capital-backed VC for scale. Each rung is sequenced, not chosen.
**Common Mistakes**
- Raising equity to fund what a grant would fund — wastes dilution. - Relying on grants past the technical-risk stage — slows commercial momentum. - Treating R&D Tax Relief as growth capital — it is a relief, not a runway.
**Conservative Note**
This is editorial guidance about sequencing. Specific tax, dilution and investor decisions should be taken with a SEIS/EIS-specialist accountant and qualified corporate-finance adviser.
Alternative routes
Where the primary recommendation is not the right fit, these are the programmes most commonly considered alongside it.
- Innovate UK Innovation Loans
loan · £100k–£2m
- Seed Enterprise Investment Scheme (SEIS)
tax_incentive · Up to £250k raised
- Enterprise Investment Scheme (EIS)
tax_incentive · Up to £12m raised
- British Patient Capital
equity · Funding levels vary and should be confirmed through the official scheme guidance.
- R&D Tax Relief
tax_incentive · Up to ~27p per £1 of R&D spend
Common mistakes
- Starting with the largest scheme rather than the highest-fit scheme.
- Treating funding as a one-off project rather than a 24-month strategy.
- Underestimating the documentation effort: prior trading, prior R&D, finance pack.
- Missing the interaction between grant income and downstream R&D tax relief.
- Engaging a contingent-fee broker before checking whether the scheme is broker-eligible.
- Self-selecting out of a programme based on an optimistic read of eligibility.
Decision checklist
- Confirm your business stage, region and headcount against scheme thresholds.
- Map the next 24 months of funding need before applying to any one programme.
- Identify the official source for each programme on your shortlist.
- Quantify match-funding and staged-drawdown impact on cashflow.
- Check subsidy-control / de minimis ceilings across stacked awards.
- Model the interaction with R&D tax relief on subsidised costs.
- Decide whether the assessment timeline fits your delivery plan.
- Schedule the application in the calendar before committing operator hours.
Frequently asked questions
- What is this decision guide about?
- How to know when grant funding has done its job and equity is the next right step.
- Which funding stage does this guide cover?
- Programmes referenced here target: any, growth, startup.
- What types of funding are compared?
- This guide considers: grant, loan, tax_incentive, equity.
- How much funding could I access?
- Innovate UK Smart Grants: £100k–£2m. Innovate UK Innovation Loans: £100k–£2m. Seed Enterprise Investment Scheme (SEIS): Up to £250k raised. Enterprise Investment Scheme (EIS): Up to £12m raised. British Patient Capital: Funding levels vary and should be confirmed through the official scheme guidance.. R&D Tax Relief: Up to ~27p per £1 of R&D spend.
- Who is eligible for the recommended routes?
- UK-registered businesses of any size carrying out R&D in the UK.
- How long will it take to receive funding?
- Realistic working timeline: • **Weeks -8 to -6:** Competition scope review, eligibility check, decision to bid. • **Weeks -6 to -3:** Drafting — technical, commercial, team, project plan sections in parallel. • **Weeks -3 to -1:** Budget finalisation, match funding evidence, internal review, external critical review. • **Final week:** IFS portal upload, finance form, validation, submission at least 24 hours before deadline (the portal slows materially in the final hours). • **Post-submission:** Decision typically 8–12 weeks after the competition closes. Successful applicants enter Project Setup; unsuccessful applicants receive scored feedback that is genuinely useful for a future attempt.
- Can I apply to more than one of these programmes?
- Some combinations are permitted, others are restricted by subsidy-control rules or scheme-specific exclusivity clauses. Refer to the latest programme guidance before stacking applications.
- Will receiving a grant affect my R&D tax relief claim?
- It can. Grant-subsidised R&D expenditure is often relievable only at a reduced rate, and the interaction depends on which scheme funded which costs. FundingAtlas could not verify the interaction for every combination; confirm with a qualified adviser.
- What if my situation does not match any of the recommended routes?
- Use the Funding Finder to build a personalised shortlist, or request a Funding Strategy Review for a reviewer-led assessment.
- Where do I find the official source for each programme?
- Innovate UK Smart Grants: https://apply-for-innovation-funding.service.gov.uk/competition/search — Innovate UK Innovation Loans: https://www.ukri.org/ — Seed Enterprise Investment Scheme (SEIS): https://www.gov.uk/guidance/venture-capital-schemes-apply-for-the-seed-enterprise-investment-scheme — Enterprise Investment Scheme (EIS): https://www.gov.uk/guidance/venture-capital-schemes-apply-for-the-enterprise-investment-scheme — British Patient Capital: https://www.britishpatientcapital.co.uk/our-portfolio/ — R&D Tax Relief: https://www.gov.uk/guidance/corporation-tax-research-and-development-rd-relief
Next steps
Related grants
More decision guides